Search

scAAV9.U7.ACCA

Developed by Nationwide Children’s Hospital, it is being investigated for the treatment of Duchenne muscular dystrophy. … scAAV9.U7.ACCA is a non-replicating recombinant adeno-associated virus vector containing 4 antisense sequences designed to target exon 2 in the human DMD gene under the control of U7 small nuclear non-coding

Iolopride I-123

The usage of the INN stem '-pride' in the name indicates that Iolopride I-123 is a sulpiride derivative and analogue. Iolopride I-123 has a monoisotopic molecular weight of 400.06 Da.

Methylpropylpropanediol dinitrate

WP-1122

It was granted FDA orphan designation for the treatment of glioblastoma multiforme.[L47361]

mRNA-3351

Developed by Moderna, it is currently being investigated as the treatment for Crigler-Najjar syndrome

AGS-004

This approach may overcome the weaknesses of other available therapies and therefore could result in a better chance of success for HIV treatment. … Non-personalized HIV immunotherapies are unable to raise cytotoxic T lymphocytes against HIV antigens, fail to induce T cell memory, and, most importantly, do not provide antiviral protection against the

Mebendazole

A benzimidazole that acts by interfering with carbohydrate metabolism and inhibiting polymerization of microtubules. [PubChem]

Aminoethyl nitrate

Trimethyltetradecylammonium

3,4-Dihydroxycinnamic Acid